Kenneth Mills
Founder bei REGENXBIO INC.
Vermögen: 9 Mio $ am 31.03.2024
Profil
Kenneth T.
Mills is the founder of REGENXBIO, Inc. founded in 2008, where he holds the titles of President, Chief Executive Officer & Director.
He previously worked as Director-Business Development at IGEN International, Inc. from 1997 to 2003, as Chief Financial Officer & VP-Business Development at Meso Scale Diagnostics LLC from 2004 to 2006, and as Partner at FoxKiser LLP from 2007 to 2015.
Mr. Mills received his undergraduate degree from Massachusetts Institute of Technology in 1997.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
REGENXBIO, INC.
0,83% | 15.04.2024 | 408 035 ( 0,83% ) | 9 Mio $ | 31.03.2024 |
Aktive Positionen von Kenneth Mills
Unternehmen | Position | Beginn |
---|---|---|
REGENXBIO INC. | Founder | 16.07.2008 |
Ehemalige bekannte Positionen von Kenneth Mills
Unternehmen | Position | Ende |
---|---|---|
FOXKISER LLP
FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services FOXKISER LLP engages in the provision of strategic advice and counseling services to pharmaceutical and biotechnology companies. Its project works fall into three general categories: advisory services; long-term partnerships; and new company formation. The company was founded by John Daniel Kiser and Allan M. Fox in September 1986 and is headquartered in Washington, DC. | Corporate Officer/Principal | 01.01.2015 |
Meso Scale Diagnostics LLC
Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD. | Director of Finance/CFO | 01.12.2006 |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.12.2003 |
Ausbildung von Kenneth Mills
Massachusetts Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
REGENXBIO INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Health Technology |
Meso Scale Diagnostics LLC
Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD. | Health Technology |
FOXKISER LLP
FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services FOXKISER LLP engages in the provision of strategic advice and counseling services to pharmaceutical and biotechnology companies. Its project works fall into three general categories: advisory services; long-term partnerships; and new company formation. The company was founded by John Daniel Kiser and Allan M. Fox in September 1986 and is headquartered in Washington, DC. | Commercial Services |